Aquestive Therapeutics EV - Enterprise Value 2011-2026 | AQST

Annual EV - Enterprise Value Aquestive Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
540 M	332 M	397 M	189 M	264 M	258 M	137 M	164 M	69.6 M	57 M	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
540 M	57 M	241 M

EV - Enterprise Value of other stocks in the Biotechnology industry

Issuer	EV - Enterprise Value	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	1.82 B	-	2.43 %	$ 254 M	Germany
Amphastar Pharmaceuticals AMPH	1.92 B	$ 21.69	1.31 %	$ 1.01 B	USA
I-Mab IMAB	8.28 B	-	-	$ 866 M	China
Aeglea BioTherapeutics AGLE	-23.2 M	-	-	$ 1.01 B	USA
Midatech Pharma plc MTP	-1.76 M	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	1.95 B	-	-	$ 40.3 B	USA
Aptorum Group Limited APM	9.45 M	$ 0.91	1.61 %	$ 6.69 M	China
Biophytis SA BPTS	525 M	-	-13.47 %	$ 169 M	France
Genfit SA GNFT	168 B	-	2.54 %	$ 160 B	France
ACADIA Pharmaceuticals ACAD	3.33 B	$ 22.3	1.55 %	$ 3.7 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	3.41 B	-	-1.52 %	$ 24.7 M	USA
Advaxis ADXS	-3.02 M	-	-9.65 %	$ 45.9 M	USA
AIkido Pharma AIKI	9.53 M	-	1.93 %	$ 17.4 M	USA
Akouos AKUS	95.1 M	-	0.23 %	$ 488 M	USA
Allakos ALLK	122 M	-	-	$ 28.6 M	USA
AlloVir ALVR	-55.1 M	-	4.14 %	$ 49.1 M	USA
Ampio Pharmaceuticals AMPE	-1.05 M	-	-11.43 %	$ 502 K	USA
Институт стволовых клеток человека ISKJ	14.1 M	-	-	-	Russia
Applied Molecular Transport AMTI	7.6 M	-	-	$ 10.1 M	USA
Aeterna Zentaris AEZS	10.3 M	-	5.93 %	$ 314 M	Canada
Brainstorm Cell Therapeutics BCLI	11 M	-	-2.5 %	$ 5.88 M	USA
Applied Therapeutics APLT	563 M	-	-	$ 8.42 M	USA
Aptinyx APTX	-18.3 M	-	-39.0 %	$ 4.57 M	USA
AgeX Therapeutics AGE	3.93 M	-	-10.17 %	$ 12.2 K	USA
Aravive ARAV	58.2 M	-	-13.39 %	$ 1.45 M	USA
Aridis Pharmaceuticals ARDS	38.2 M	-	17.91 %	$ 11.1 M	USA
BioNTech SE BNTX	-4.91 B	$ 102.42	-2.88 %	$ 27.2 B	Germany
Avenue Therapeutics ATXI	-1.76 M	-	-52.27 %	$ 4.45 M	USA
Applied Genetic Technologies Corporation AGTC	-9.16 M	-	-	$ 26.5 M	USA
Arcutis Biotherapeutics ARQT	3.64 B	$ 23.34	0.32 %	$ 2.97 B	USA
Ayala Pharmaceuticals AYLA	5.32 M	-	-	$ 7.46 M	Israel
Autolus Therapeutics plc AUTL	629 M	$ 1.43	-0.69 %	$ 381 M	Britain
Aptose Biosciences APTO	36.2 M	-	-45.71 %	$ 1.2 M	Canada
AstraZeneca PLC AZN	59.6 B	-	-	$ 96.9 B	Britain
AVROBIO AVRO	-35.4 M	-	1083.1 %	$ 745 M	USA
Can-Fite BioPharma Ltd. CANF	647 M	$ 2.9	-0.34 %	$ 4.77 M	Israel
Esperion Therapeutics ESPR	1.16 B	$ 1.92	0.54 %	$ 399 M	USA
BioDelivery Sciences International BDSI	445 M	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	-720 M	-	0.49 %	$ 251 B	Cayman-islands
Akero Therapeutics AKRO	2.99 B	-	-	$ 3.67 B	USA
CureVac N.V. CVAC	3.19 B	-	-	$ 867 M	Germany
bluebird bio BLUE	270 M	-	-	$ 546 M	USA
ContraFect Corporation CFRX	24.7 M	-	-5.16 %	$ 5.39 M	USA
Cardiff Oncology CRDF	115 M	$ 1.72	-	$ 115 M	USA
BioXcel Therapeutics BTAI	127 M	$ 1.09	1.89 %	$ 13.3 M	USA
Cabaletta Bio CABA	253 M	$ 2.95	-0.17 %	$ 296 M	USA
Cara Therapeutics CARA	-9.61 M	-	-3.03 %	$ 260 M	USA
Allena Pharmaceuticals ALNA	-14.1 M	-	3.16 %	$ 1.9 M	USA
CASI Pharmaceuticals CASI	1.08 B	-	-	$ 35.4 M	USA